Question 1

How does Molecular Theranostics (United States) rank in research?

Accepted Answer

Molecular Theranostics (United States) ranks #21,752 of 22,385 institutions worldwide on research quality in 2022-now, and #3,232 of 3,332 in the United States.

Question 2

Who are the top researchers at Molecular Theranostics (United States)?

Accepted Answer

Ranked on the quality score, Zachary Ells lead among researchers whose main affiliation is Molecular Theranostics (United States).

Question 3

What are the most cited papers from Molecular Theranostics (United States)?

Accepted Answer

The most cited paper from Molecular Theranostics (United States) is "18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial" (Jérémie Calais et al., 2019), with 477 citations. Next come "E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET" (372) and "A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)" (317).

Question 4

Which research topics does Molecular Theranostics (United States) publish most on?

Accepted Answer

By volume in 2022-now: Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Prostate Cancer Diagnosis and Treatment and Peptidase Inhibition and Analysis.

Question 5

Which keywords describe research at Molecular Theranostics (United States)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Prostate Cancer, Immunotherapy, PET Imaging, Genetic Mutations, Clinical Trials, Biomarkers, Targeted Therapy and Genomic Profiling.

Question 6

Which fields of science does Molecular Theranostics (United States) work in?

Accepted Answer

In 2022-now, 66% of research at Molecular Theranostics (United States) is in Health Sciences, 18% in Life Sciences. Its largest fields are Medicine (66%), Biochemistry, Genetics and Molecular Biology (14%), Engineering (8%). It does 2.6× the world's share of Health Sciences.

Question 7

Is Molecular Theranostics (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 161% higher than in 2018-2021.